糖心原创

School of Pharmacy

Image of David Heery

David Heery

Professor of Eukaryotic Gene Regulation, Faculty of Science

Contact

Biography

David M. Heery is a molecular biologist and lead of the Gene Regulation & RNA Biology Laboratory located within the BioDiscovery Institute, 糖心原创. He is current head of the Division of Biomolecular Science and Medicinal Chemistry within the School of Pharmacy, Faculty of Science. David completed his PhD at NUI, Galway, Ireland working with L. Kieran Dunican on coryneform gene regulation (Heery & Dunican NAR 1990; Heery et al, AEM, 1993; Heery et al, BBRC 1994) and also collaborated with the group of Frank Gannon publishing several molecular biology methods papers.

From 1990-1995 he undertook postdoctoral research within the groups of Pierre Chambon & Regine Losson at the IGBMC Strasbourg, France (1990-1995) supported by fellowships from EMBO, the Association pour la Recherche sur la Cancer and the University Louis Pasteur. His focus was on Nuclear Receptor functions in transcription and development of yeast two-hybrid approaches to identify transcriptional cofactors (e.g. Pierrat et al, Gene 1992; Gilbert et al, MCB 1993; Heery et al, PNAS 1993; Heery et al, NAR 1994; Pierrat et al, Gene 1994; LeDouarin et al, EMBO J 1995; vom Baur et al, EMBO J 1996).

In 1995 he joined Imperial Cancer Research, London as a Marie Curie Fellow, where a major advance was the identification of the LXXLL motifs that mediate NR/cofactor interactions (e.g. Heery et al Nature 1997; Kalkhoven et al, EMBO J; Bevan et al, Mol Cell Biol 1999) resulting in a patented platform for drug discovery applications.

David was awarded a Wellcome Trust Senior Fellowship in Basic Biomedical Sciences (1998-2006) to establishing his group at the Dept. of Biochemistry, University of Leicester before transferring to the School of Pharmacy Nottingham in 2005. This expanded his work on the structure function of NRs and their cofactors, (e.g. Heery et al, JBC 2001; Sheppard et al, Mol Cell Biol 2001; Coulthard et al, JBC 2003; Matsuda et al JBC 2004; Waters et al JBC 2006; Ryan et al Cell Cycle 2006) as well as switch of focus to the study epigenetic regulators such as MOZ/KAT6A histone acetyltransferase and its role as an oncogenic fusion protein in AML (Kindle et al Mol Cell Biol 1995; Collins et al, JBC 1996). His group at the School of Pharmacy Nottingham has continued these research themes (e.g. Kindle et al, Leukemia 2010; Chan et al NAR 2013, Wadelin et al PLOS One 2013; Collins et al., BMC Cancer 2013; Dreveny et al NAR 2014; Fulton et al, CDDis 2017; Garvin et al NAR 2019; Monteiro et al. Adv Exp Med Biol 2023; Chrisp et al Sci Reports 2025) as well as collaborative projects with colleagues at Nottingham and internationally e.g. Simak Ali (Imperial) Lukas Kenner & Brigitte Hantusch (Univ. Vienna), Jenny Persson (Univ. Umea).

David's current research focus is on the structure and function of the KAT6A and KATB genes associated with neurdevelopmental disorders in collaboration with Ralf Flaig and Marco Mazzorana at Diamond Light Source.

Expertise Summary

Molecular & Cell Biology

CRISPR CAS9 Genome Editing

Protein-Protein & Protein-DNA Interactions

Nuclear Receptor Signaling; Transcription Factors & Coactivators

Histone Modifications; Chromatin Recognition, Oncogenic Fusion Proteins

Cancer- Leukemia; Prostate Cancer; Breast Cancer

Confocal Microscopy, Cell-based Assays, RNA Seq, Chromatin -IP,

Protein Structure/ Function Studies

MYST Acetyltransferases

PIP5K1A Function

Teaching Summary

I deliver teaching and assessment on number of modules/ teaching blocks across several of the degree courses offered by the School of Pharmacy, the details of which are outlined below. The topics… read more

Research Summary

Prof. David Heery's research team is housed within the Gene Regulation & RNA Biology Laboratory (GRRB) located in the Psychology/Pharmacy Building Science Road, Main Campus. Our research is… read more

Selected Publications

  • KAUR, I., SCHRAMM, G., EVERTS, B., SCHOLZEN, T., KINDLE, K.B., BEETZ, C., MONTIEL-DUARTE, C., BLINDOW, S., JONES, A.T., HAAS, H., STOLNIK, S., HEERY, D.M. and FALCONE, F.H., 2011. Infection and Immunity. 79(4), 1779-1788
  • RYAN, COLM M, KINDLE, KARIN B, COLLINS, HILARY M and HEERY, DAVID M, 2010. Biochemical and biophysical research communications. 391(1), 1136-41
  • KINDLE, K.B., COLLINS, H.M. and HEERY, D.M., 2010. Leukemia. 24(7), 1359-1361
  • CANNELL, I.G., KONG, Y.W., JOHNSTON, S.J., CHEN, M.L., COLLINS, H.M., DOBBYN, H.C., ELIA, A., KRESS, T.R., DICKENS, M., CLEMENS, M.J., HEERY, D.M., GAESTEL, M., EILERS, M., WILLIS, A.E. and BUSHELL, M., 2010. Proceedings of the National Academy of Sciences of the United States of America. 107(12), 5375-5380

Current Group Members

- Group Leader

Dr. Hilary M Collins -Senior Experimental Officer/ formerly CRUK PDRA

Christopher Roberts BBSRC DTP

Mitchell Masterson BBSRC DTP (with Prof PM Moran)

Jonas Schoenfeld MRes

Ryan Morris BBSRC DTP

Ruby Chrisp BBSRC DTP (with Prof PM Moran)

Barbara Rampersad Technician

ALUMNI from the DMH Lab

Dr Jonathan Whitchurch BBSRC DTP

Dr Cintia Monteiro CAPES Science without Borders

Dr. Bismoy Mazumder Vice Chancellor Scholarship

Dr. Miguel Hernandez MRes

Dr Maria Clemente MRes

Dr Amit Bhattacharrya MRes

Dr Neetu Bharti MRes

Dr. Joel Fulton - RPSGB scholar; CRUK Research Associate

Dr. Chun Chan Leukemia Research Gordon Pillar scholarship

Olaide Oyegbami PhD Student (with Prof PM Moran)

Dr Nikolaos Tertipis - MSc student

Dr. Sian Deeves - BBSRC scholarship

Dr. Magdy K Abdelghany PhD Scholarship (Egyptian Govt.)

Dr. Baigong Yue MRC Postdoctoral Fellow

Dr. Frances Wadelin Leukaemia Research- Clinical Training Fellow

Dr. Marie Messmer CRUK Postdoctoral Fellow

Dr. Karin Kindle LLR/AICR/Wellcome Trust Postdoctoral Fellow

Dr. Cristina Montiel-Duarte LLR/AICR Postdoctoral Fellow

Dr. Colm Ryan BBSRC Studentship

Dr. Chun Ming Chan LLR Gordon Piller PhD Studentship

Dr. Cecilie Bay-Richter PhD Student (with Prof P Moran)

Dr. Nijjareeya Sirisriro PhD student

Dr. Maria Viskaduraki LLR Postdoctoral Fellow

Hao Liu MSc student

Dr. Lorna Waters BBSRC PhD Student (with Dr Mark Carr)

Dr. Sachiko Matsuda Wellcome Trust RA/ PhD Student

Dr. Janet Bramham Wellcome Trust Postdoctoral Fellow

Dr. Victoria Coulthard Wellcome Prize PhD Student

Dr. Sagair Hussain MSc Student

Dr. Phil Troke MRC PhD scholarship

Dr. Hilary Sheppard Wellcome Trust Postdoctoral Fellow

Ms. Jan Harries Wellcome Trust Research Assistant

I deliver teaching and assessment on number of modules/ teaching blocks across several of the degree courses offered by the School of Pharmacy, the details of which are outlined below. The topics covered fall largely within my research expertise, including recombinant DNA technology, gene regulation, endocrinology and cancer, physiology, microbiology and cell signalling pathways, thus enabling research-led teaching.

TEACHING & MODULE MANAGEMENT

Degree: M.Pharm. Pharmacy

PHAR2004 B32RED Renal & Endocrine Disease: Module Convenor

PHAR2001 B32GIL GI & Liver Disorders

PHAR4020 B34PLM Professional Leadership & Management

PHAR3005 B33RPJ Research Projects

PHAR1006 B31PRO /B31PC1 Professional Competencies

PHAR2008 B32PRO /B32PC2 Professional Competencies

PHAR3004 B33PRO /B33PC3 Professional Competencies

PHAR4022 B34PRO /B34PC4 Professional Competencies

Degree : BSc International Pharmacy

PHAR2027 B32RAE Renal & Endocrine Disease: Module Convenor

PHAR2025 B32GLD GI & Liver Disorders

Degree: M.Pharm Sci

PHAR1019 B31EAM Endocrine & Metabolism

PG Training Module:

'Introduction to Gene Regulation'

Current Research

Prof. David Heery's research team is housed within the Gene Regulation & RNA Biology Laboratory (GRRB) located in the Psychology/Pharmacy Building Science Road, Main Campus. Our research is focussed on molecular mechanisms in gene regulation, chromatin modification and cell signalling pathways, in the context of cancer and other human diseases. Our lab infrastructure has facilities for bacterial, yeast and mammalian cell culture, biochemistry, molecular and cell biology and confocal microscopy. My team has expertise in protein, DNA and RNA analysis, molecular cloning, bacterial expression, RT-qPCR, enzyme and reporter assays, chromatin IP, transcription profiling, histone modifications, protein-protein and protein-nucleic acid interactions including yeast two-hybrid, GST pulldown, co-immunoprecipitations, EMSA and FRET.

CURRENT PROJECTS:

STRUCTURE / FUNCTION OF NUCLEAR RECEPTOR COMPLEXES

I have a long-standing interest in transcription factors, and in particular the Nuclear Receptor family of ligand regulated TFs. We have investigated protein-DNA and protein-protein interactions of NRs, identifying novel heterodimer complexes and discovering short conserved motifs such as the LXXLL in NR coactivators (Heery et al., PNAS 1992; Heery et al NAR 1994; Heery et al., Nature 1997; Heery et al JBC 2001; Kalkhoven et al., 1998 EMBO J; Bevan et al., Mol Cell Biol 1999; Coulthard et al JBC 2003; Matsuda et al., JBC 2004;Waters et al., JBC 2006; Chan et al NAR 2013; Fulton et al, Cell Death Disease 2017). Recent efforts have focussed on androgen receptor function in collaboration with Prof Lukas Kenner at the Ludwig Boltzmann Institute for Cancer Research, Vienna (Aksoy et al., 2019 submitted).

HISTONE ACETYLTRANSFERASES IN CANCER AND DEVELOPMENTAL DISORDERS

Another major interest is how 'Epigenetic regulators' engage with histones and chromatin to regulate gene expression. Having studied NR coactivators such as RIP140, SRC1, CBP, p300 and BCL11A, we are currently focussed on investigating the structure and function of the MYST acetyltransferase proteins MOZ and MORF that are encoded by the KAT6A and KAT6B genes. These are important for the development of blood, brain and other tissues and function as chromatin regulators, and we have previously studied their role as oncogenic fusion proteins in leukemia (Kindle et al., 2005 MCB; Collins et al., 2006 JBC; Kindle et al., 2010 Leukaemia 2010).

Our Breakthrough paper published in Nucleic Acids Research showed that the Double PHD finger domain recognises specific modifications of lysines and arginines in the Histone H3 tail. Moreover, crystal structures of the DPF in complex with acetylated H3 peptides revealed for the first time that chromatin regulators can induce helical structure in Histone N-terminal tails (Dreveny, Deeves et al, NAR 2014). We are currently using CRISPR CAS9 genome editing and RNA Seq to identify MOZ gene targets and characterise MOZ functional domains important for gene transcription and leukemogenesis, or to recapitulate mutations associated with KAT6A global developmental delay syndrome.

UNDERSTANDING GENE FUNCTION THROUGH GENOME EDITING

We have a number of ongoing collaborations involving CRISPR CAS9 editing of selected genes in cancer cell lines including with Dr Alan McIntyre (BET proteins in Breast Cancer- funded by Breast Cancer Now); Prof Nigel Mongan (KDM6A- funded by Prostate Cancer UK; and METTL3 function in prostate cancer); Dr. Anna Piccinini (TNC gene in macrophages); Prof Paula Moran (circadian regulation by CLOCK proteins). We are also using genome editing and RNA Seq to study the role of PIP2 signalling in prostate cancer with a view to understanding how it intersects with Androgen Receptor function. This is part of a wider collaborative effort to identify novel targets in prostate cancer in collaboration with Prof. J Persson Umea, Sweden and others (Miftakhova et al., Cancer Research 2016; Sarwar et al., Oncotarget 2016).

OTHER PROJECTS:

Other recent studies include the characterisation of human cell nucleus infiltration by proteins secreted from schistosome eggs with Franco Falcone (Kaur et al., Infection & Immunity, 2014; Pennington et al., Infection & Immunity, 2017) , functional analysis of AR mutations in DSD patients with Prof Ieuan Hughes, Cambridge (Lek et al., EBioMedicine 2019 and circadian histone acetylation and dopamine receptorswith Prof Paula Moran (O'Callaghan et al. J. Psychopharm 2014; Oyegbami et al., Current Alzheimers Research 2017). A new collaboration with Dr Simon Johnston (NRF fellow) and colleagues will investigate FOXA1 mutations in invasive lobular breast cancer using RIME analysis of human tumours (funded by AMS).

EXTERNAL FUNDING:

Our research activities have been funded by grants, fellowships and studentships awarded by the Wellcome Trust Cancer Research UK, MRC, Leukaemia Lymphoma Research, AICR, BBSRC, RPSGB, Breast Cancer Now and Prostate Cancer UK.

  • GARVIN AJ, KHALAF AHA, RETTINO A, XICLUNA J, BUTLER L, MORRIS JR, HEERY DM and CLARKE NM, 2019. Nucleic acids research. 47(9), 4476-4494
  • LEE JB, ZGAIR A, MALEC J, KIM TH, KIM MG, ALI J, QIN C, FENG W, CHIANG M, GAO X, VORONIN G, GARCES AE, LAU CL, CHAN TH, HUME A, MCINTOSH TM, SOUKARIEH F, AL-HAYALI M, CIPOLLA E, COLLINS HM, HEERY DM, SHIN BS, YOO SD, KAGAN L, STOCKS MJ, BRADSHAW TD, FISCHER PM and GERSHKOVICH P, 2018. Journal of controlled release : official journal of the Controlled Release Society. 286, 10-19
  • LEK, NGEE, TADOKORO-CUCCARO, RIEKO, WHITCHURCH, JONATHAN B., MAZUMDER, BISMOY, MILES, HARRIET, PRENTICE, PHILIPPA, BUNCH, TREVOR, ZIELINSKA, KAROLINA, METZLER, VERONIKA, MONGAN, NIGEL P., HEERY, DAVID M. and HUGHES, IEUAN A., 2018. EBIOMEDICINE. 36, 401-409
  • HEERY DM, 2018. Blood. 131(16), 1771-1773
  • METZLER VM, DE BROT S, ROBINSON RS, JEYAPALAN JN, RAKHA E, WALTON T, GARDNER DS, LUND EF, WHITCHURCH J, HAIGH D, LOCHRAY JM, ROBINSON BD, ALLEGRUCCI C, FRAY RG, PERSSON JL, 脴DUM N, MIFTAKHOVA RR, RIZVANOV AA, HUGHES IA, TADOKORO-CUCCARO R, HEERY DM, RUTLAND CS and MONGAN NP, 2017. Placenta. S0143-4004(17), 30164-9
  • FULTON J, MAZUMDER B, WHITCHURCH JB, MONTEIRO CJ, COLLINS HM, CHAN CM, CLEMENTE MP, HERNANDEZ-QUILES M, STEWART EA, AMOAKU WM, MORAN PM, MONGAN NP, PERSSON JL, ALI S and HEERY DM, 2017. Cell death & disease. 8(3), e2677
  • OYEGBAMI O, COLLINS HM, PARDON MC, EBLING FJ, HEERY DM and MORAN PM, 2017. Current Alzheimer research. 14, 850-860
  • ATIOMO W, SHAFIEE MN, CHAPMAN C, METZLER VM, ABOUZEID J, LATIF A, CHADWICK A, KITSON S, SIVALINGAM VN, STRATFORD IJ, RUTLAND CS, PERSSON JL, 脴DUM N, FUENTES-UTRILLIA P, JEYAPALAN JN, HEERY DM, CROSBIE EJ and MONGAN NP, 2017. Clinical endocrinology.
  • PENNINGTON LF, ALOUFFI A, MBANEFO EC, RAY D, HEERY DM, JARDETZKY TS, HSIEH MH and FALCONE FH, 2017. Infection and Immunity. 85(12),
  • MIFTAKHOVA R, HEDBLOM A, SEMENAS J, ROBINSON B, SIMOULIS A, MALM J, RIZVANOV A, HEERY DM, MONGAN NP, MAITLAND NJ, ALLEGRUCCI C and PERSSON JL, 2016. Cancer Research. 76(8), 2453-64
  • SARWAR M, SEMENAS J, MIFTAKHOVA R, SIMOULIS A, ROBINSON BD, WINGREN AG, MONGAN NP, HEERY DM, JOHNSSON H, ABRAHAMSSON PA, DIZEYI N, LUO J and PERSSON JL, 2016. Oncotarget. (In Press.)
  • DE BROT S, NTEKIM A, CARDENAS R, JAMES V, ALLEGRUCCI C, HEERY D, BATES DO, ODUM N, PERSSON JL and MONGAN NP, 2015. Endocrine-related cancer. 22(3), R107-23
  • NILSSON EM, LAURSEN KB, WHITCHURCH J, MCWILLIAM A, ODUM N, PERSON JL, HEERY DM, GUDAS LJ and MONGAN NP, 2015. Oncotarget. 6(34), 35710-25
  • CHOONG SS, FULTON J,, EMES RD, YON L, HEERY DM and MONGAN NP, 2015. Retinoids: Nutritional, Cellular and Pharmacological roles of the Vitamin A derivatives Reference Module in Biomedical Sciences.
  • DREVENY, I., DEEVES, S.E., FULTON, J., YUE, B., MESSMER, M., BHATTACHARYA, A., COLLINS, H.M. and HEERY, D.M., 2014. Nucleic Acids Research. 42(2), 822-835
  • O鈥� CALLAGHAN MJ, BAY-RICHTER C, O鈥橳UATHAIGH CMP, HEERY DM, WADDINGTON JL and MORAN PM, 2014. Journal of Psychopharmacology. 28(10), 973-977
  • COLLINS HM, ABDELGHANY MK, MESSMER M, YUE B, DEEVES SE, KINDLE KB, MANTELINGU K, ASLAM A, WINKLER GS, KUNDU TK and HEERY DM, 2013. BMC cancer. 13(1), 37
  • BAY-RICHTER, C., O'CALLAGHAN, M.J., MATHUR, N., O'TUATHAIGH, C.M.P., HEERY, D.M., FONE, K.C.F, WADDINGTON, J.L. and MORAN, P.M., 2013. Neuropsychopharmacology. 38(8), 1512-1520
  • WADELIN FR, FULTON J, COLLINS HM, TERTIPIS N, BOTTLEY A, SPRIGGS KA, FALCONE FH and HEERY DM, 2013. PloS one. 8(2), e58052
  • CHAN, C.M., FULTON, J., MONTIEL-DUARTE, C., COLLINS, H.M., BHARTI, N., WADELIN, F.R., MORAN, P.M., MONGAN, N.P. and HEERY, D.M., 2013. Nucleic Acids Research. 41(21), 9663-9679
  • KAUR, I., SCHRAMM, G., EVERTS, B., SCHOLZEN, T., KINDLE, K.B., BEETZ, C., MONTIEL-DUARTE, C., BLINDOW, S., JONES, A.T., HAAS, H., STOLNIK, S., HEERY, D.M. and FALCONE, F.H., 2011. Infection and Immunity. 79(4), 1779-1788
  • RYAN, COLM M, KINDLE, KARIN B, COLLINS, HILARY M and HEERY, DAVID M, 2010. Biochemical and biophysical research communications. 391(1), 1136-41
  • KINDLE, K.B., COLLINS, H.M. and HEERY, D.M., 2010. Leukemia. 24(7), 1359-1361
  • CANNELL, I.G., KONG, Y.W., JOHNSTON, S.J., CHEN, M.L., COLLINS, H.M., DOBBYN, H.C., ELIA, A., KRESS, T.R., DICKENS, M., CLEMENS, M.J., HEERY, D.M., GAESTEL, M., EILERS, M., WILLIS, A.E. and BUSHELL, M., 2010. Proceedings of the National Academy of Sciences of the United States of America. 107(12), 5375-5380
  • WADELIN, F., FULTON, J., MCEWAN, P.A., SPRIGGS, K.A., EMSLEY, J. and HEERY, D.M., 2010. Molecular Cancer. 27(9), 226
  • ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Cancer Research. 69(9), 3802-3809
  • BAY-RICHTER, C., O'TUATHAIGH, C.M.P., O'SULLIVAN, G., HEERY, D.M., WADDINGTON, J.L. and MORAN, P.M., 2009. International Journal of Neuropsychopharmacology. 12(3), 403-414
  • CRISTIAN BELLODI, KARIN KINDLE, FRANCESCA BERNASSOLA, ANDREA COSSARIZZA,DAVID DINSDALE, GERRY MELINO, DAVID M. HEERY AND PAOLO SALOMONI, 2007. Cell Cycle. 5(22), 2688-2692
  • EL-SHEIKH, S., GREEN, A.R., RAKHA, E.A., AHMED, R.A., PAIS, E.C., GRAINGE, M.J., BALL, G.R., ROBERTSON, J.F., HEERY, D.M. and ELLIS, I.O., 2007. EJC Supplements. 5(3), 14-14
  • DAVID M HEERY & PETER M FISCHER, 2007. Drug Discovery Today. 12(1-2), 88-99
  • EL-SHEIKH, S.E., GREEN, A.R., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and ELLIS, I.O., 2007. Global histone modifications in breast cancer and their prognostic significance Modern Pathology. 20, 29A-30A
  • LOPEZ-GARCI, J, THOMAS R, PERIYASAMY M and CHRISTIAN M, LEAO M, JAT P, KINDLE KB, HEERY DM, PARKER MG, BULUWELA L, KAMALATI T & ALI S, 2007. ZNF366 is a Novel Transcriptional Co-repressor that Regulates Estrogen Receptor Activity Through the Recruitment of CtBP and Histone Deacetylases. Nucleic Acids Research. 33(19), 6393-6404
  • EL-SHEIKH, S.E., GREEN, A.R., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and ELLIS, I.O., 2007. Global histone modifications in breast cancer and their prognostic significance Laboratory Investigation. 87, 29A-30A
  • FAHEY, A.J., ROBINS, R.A., KINDLE, K.B., HEERY, D.M. and CONSTANTINESCU, C.S., 2006. Journal of Leukocyte Biology. 80(1), 133-144
  • COLLINS, H.M., KINDLE, K.B., MATSUDA, S., RYAN, C., TROKE, P.J.F., KALKHOVEN, E. and HEERY, D.M., 2006. Journal of Biological Chemistry. 281(25), 17124-17133
  • RYAN, COLM M, HARRIES, JANET C, KINDLE, KARIN B, COLLINS, HILARY M and HEERY, DAVID M, 2006. Functional interaction of CREB binding protein (CBP) with nuclear transport proteins and modulation by HDAC inhibitors. Cell Cycle. 5(18), 2146-52
  • TROKE, PHILIP J F, KINDLE, KARIN B, COLLINS, HILARY M and HEERY, DAVID M, 2006. MOZ fusion proteins in acute myeloid leukaemia. Biochemical Society symposium.. 23-39
  • BELLODI, CRISTIAN, KINDLE, KARIN, BERNASSOLA, FRANCESCA, DINSDALE, DAVID, COSSARIZZA, ANDREA, MELINO, GERRY, HEERY, DAVID and SALOMONI, PAOLO, 2006. Journal of Biological Chemistry. 281(20), 14465-73
  • WATERS, L., YUE, B., VEVERKA, V., RENSHAW, P., BRAMHAM, J., MATSUDA, S., FRENKIEL, T., KELLY, G., MUSKETT, F., CARR, M. and HEERY, D.M., 2006. Journal of Biological Chemistry. 281(21), 14787-95
  • GREEN, A.R., EL-SHEIKH, S., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and ELLIS, I.O., 2006. Breast Cancer Research. 8, S16-S16
  • BELLODI, C., KINDLE, K.B., BERNASSOLA, F., DINSDALE, D., COSSARIZZA, A., MELINO, G., HEERY, D.M. and SALOMONI, P., 2006. Cytoplasmic PML proteins form novel cytoplasmic bodies and inhibit p53- and retinoic acid-dependent transcription. Journal of Biological Chemistry. 281, 14465-14473 (In Press.)
  • EL-SHEIKH, S., RAKHA, E.A., PAISH, E.C., HEERY, D.M. and SALOMONI, P., 2006. Global histone modifications in breast cancer and their prognostic significance Journal of Pathology. 210, 1-1
  • BELLODI, C., KINDLE, K., BERNASSOLA, F., DINSDALE, D., COSSARIZZA, A., MELINO, G., HEERY, D. and SALOMONI, P., 2006. Cytoplasmic function of mutant PML and PML-RARalpha British Journal of Haematology. 133, 27-27
  • BELLODI, C., KINDLE, K., BERNASSOLA, F., DINSDALE, D., COSSARIZZA, A., MELINO, G., HEERY, D. and SALOMONI, P., 2006. Role of cytoplasmic forms of PML and PML-RARa in the response to therapy TOXICOLOGY -SHANNON-. VOL 226(NUMBER 1), 46-47
  • KINDLE, K.B., TROKE, P.J.F., COLLINS, H.M., MATSUDA, S., BOSSI, D., BELLODI, C., KALKHOVEN, E., SALOMONI, P., PELICCI, P.G., MINUCCI, S. and HEERY, D.M., 2005. Molecular and Cellular Biology. 25(3), 988-1002
  • LUCEY, MARIE J, CHEN, DONGSHENG, LOPEZ-GARCIA, JORGE, HART, STEPHEN M, PHOENIX, FLADIA, AL-JEHANI, RAJAI, ALAO, JOHN P, WHITE, ROGER, KINDLE, KARIN B, LOSSON, R脙漏GINE, CHAMBON, PIERRE, PARKER, MALCOLM G, SCH脙陇R, PRIMO, HEERY, DAVID M, BULUWELA, LAKJAYA and ALI, SIMAK, 2005. Nucleic Acids Research. 33(19), 6393-404
  • MATSUDA, S., HARRIES, J.C., VISKADURAKI, M., TROKE, P.J.F., KINDLE, K.B., RYAN, C. and HEERY, D.M., 2004. Journal of Biological Chemistry. 279(14), 14055-14064
  • BELLODI, C., KINDLE, K., BERNASSOLA, F., DINSDALE, D., MELINO, G., COSSARIZZA, A., HEERY, D. and SALOMONI, P., 2004. Mutant PML Proteins Form Novel Cytoplasmic Bodies. (Poster # 764-III) BLOOD -NEW YORK-. VOL 104(NUMB 11), 3494
  • SHEPPARD, H M, MATSUDA, S, HARRIES, J C, KINDLE, K B and HEERY, D M, 2003. Journal of Molecular Endocrinology. 30(3), 411-22
  • COULTHARD, V. H., MATSUDA, S. and HEERY, D. M., 2003. Journal of Biological Chemistry. VOL 278(PART 13), 10942-10951
  • GIRAUD, SANDRINE, BIENVENU, FR脙漏D脙漏RIC, AVRIL, SYLVIE, GASCAN, HUGUES, HEERY, DAVID M and COQUERET, OLIVIER, 2002. Journal of Biological Chemistry. 277(10), 8004-11
  • HEERY, D.M., HOARE, S., HUSSAIN, S., PARKER, M.G. and SHEPPARD, H., 2001. Journal of Biological Chemistry. 276(9), 6695-6702
  • SHEPPARD, H.M., HARRIES, J.C., HUSSAIN, S., BEVAN, C. and HEERY, D.M., 2001. Molecular and Cellular Biology. 21(1), 39-50
  • LE DOUARIN, B, HEERY, D M, GAUDON, C, VOM BAUR, E and LOSSON, R, 2001. Yeast two-hybrid screening for proteins that interact with nuclear hormone receptors. Methods in Molecular Biology. 176, 227-48
  • BEVAN, C.L., CLAESSENS, F., HOARE, S., HEERY, D.M. and PARKER, M.G., 1999. The AF1 and AF2 domains of the Androgen Receptor interact with distinct regions of SRC1. Molecular & Cellular Biology. 19, 8383-8392
  • WHITE, R., MAK, H-Y., HEERY, D.M., KALKHOVEN, E., VALENTINE, J., BEVAN, C. and PARKER, M.G., 1999. European Journal of Cancer. 35, 468
  • HEERY, D.M., KALKHOVEN, E., HOARE, S. and PARKER, M.G., 1997. Nature. 387, 733-736
  • LE DOUARIN, B., VOM BAUR, E., ZECHEL,C., HEERY, D.M., HEINE, M., VIVAT, V., GRONEMEYER, H., LOSSON, R. and CHAMBON, P., 1996. Philosophical Transactions of the Royal Society of London. (Part B). 351, 569-578
  • PARKER, M.G., KALKHOVEN, E., WHITE, R., HENTTU, P., SJOBERG, P., HEERY, D.M. and , 1996. Transcriptional activation by oestrogen receptors Immunology. 89, SP57-SP57
  • L'HORSET.F., DAUVOIS. S., HEERY. D.M., CAVAILLES. V. and PARKER. M.G., 1996. RIP140 interacts with multiple nuclear receptors by means of two distinct sites Molelcular & Cellular Biology. 16, 6029-6036 (In Press.)
  • VOM BAUR, E., ZECHEL, C., HEERY, D.M., HEINE, M., GARNIER, J.M., VIVAT, V., LE DOUARIN, B., GRONEMEYER, H., CHAMBON, P. and LOSSON, R., 1996. Differential ligand-dependent interactions between the AF2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 EMBO Journal. 15, 110-124
  • LE DOUARIN, B., ZECHEL, C., GARNIER, J.M., LUTZ, Y., TORA, L., PIERRAT, B., HEERY, D.M., GRONEMEYER, H., CHAMBON, P. and LOSSON, R., 1995. EMBO Journal. 14, 2020-2033
  • HEERY, D.M., PIERRAT, B., GRONEMEYER, H., CHAMBON, P. and LOSSON, R., 1994. Nucleic Acids Research. 22, 726-731
  • PIERRAT, B., HEERY, D.M., CHAMBON, P. and LOSSON, R., 1994. Gene. 143, 193-200
  • HEERY, D.M., FITZPATRICK, R. and DUNICAN, L.K., 1994. Biochemical and Biophysical Research Communications. 201, 1255-1262
  • FITZPATRICK, R., O'DONAHUE, M., JOY, J., HEERY, D.M. and DUNICAN, L.K., 1994. Journal of Applied Microbiology & Biotechnology. 42, 575-580
  • HEERY, D.M., ZACHAREWSKI, T., PIERRAT, B., GRONEMEYER, H. and CHAMBON, P., 1993. Proceedings of the National Academy of Sciences of the United States of America. 90, 4281-4285
  • GILBERT, D.M., HEERY, D.M., LOSSON, R., LEMOINE, Y. and CHAMBON, P., 1993. Molecular and Cellular Biology. 13, 462-472
  • HEERY, D.M. and DUNICAN, L.K., 1993. Cloning of the trp Gene Cluster from a Tryptophan-Hyperproducing Strain of Corynebacterium glutamicum: Identification of a Mutation in the trp Leader Sequence. Applied and Environmental Microbiology. 59, 791-799
  • HINEY, M., DAWSON, M., HEERY, D.M., SMITH, P., GANNON, F. and POWELL, R., 1992. A DNA probe for aeromonas salmonicida Applied & Environmental Microbiology. 58, 1039-1042
  • PIERRAT, B., HEERY, D.M. and LEMOINE, Y. AND LOSSON, R., 1992. Gene. 119, 237-245
  • BARRY,S., GEARY, S., HANNIFY, C., MACGEARAILT, M., HEERY, D.M., GANNON, F. and POWELL, R., 1992. Nucleic Acids Research. 20, 4940
  • HEERY, D.M. and DUNICAN, L.K., 1990. Nucleotide Sequence of the Corynebacterium glutamicum trpE Gene Nucleic Acids Research. 23, 7138
  • POWELL, R., HEERY, D.M., GANNON, F. and DUNICAN, L.K., 1990. FEMS Microbiology Letters. 72, 225-228
  • POWELL, R., HEERY, D.M., DAWSON, M., DUNICAN, L.K. and GANNON, F., 1990. Nucleic Acids Research. 18, 2190
  • HEERY, D.M., GANNON, F. and POWELL, R., 1990. A Simple Method for Subcloning DNA Fragments from Gel Slices Trends in Genetics. 6, 173
  • HEERY, D.M, and DUNICAN, L.K., 1989. Nucleic Acids Research. 17, 8006
  • HEERY, D.M., POWELL, R., GANNON, F. and DUNICAN, L.K., 1989. Nucleic Acids Research. 17, 13031
  • NEILAN, J., HEERY, D.M. and DUNICAN, L.K., 1985. Isolation of Repliation Loci of Plasmid Origin from Rhizobium trifolii Biochemical Sociey Transactions. 14, 478

School of Pharmacy

糖心原创
University Park
Nottingham, NG7 2RD

For all enquiries please visit: